As a bio based building investor and hospitality investor, I partner with founders in tourism, eco lodging, and sustainable infrastructure.
Transparency Note
I am a hospitality investor and strategic partner to founders in tourism, eco lodging, and sustainable infrastructure. This article reflects my personal investment thesis for bio based building systems — a field I entered through my portfolio of hospitality projects in emerging markets and pursued with a level of depth that taught me more than I expected. My criteria are specific and not negotiable.
My Investment Thesis in One Sentence
As a bio based building investor, I apply one rule without exception: I invest only in systems that are physically testable under real certification and application conditions and that have a clear industrial scaling perspective.
Not visions. Not simulations. Not AI generated documentation. Physical systems that can be put in front of an accredited testing laboratory within a defined timeframe.
Why This Connects to Hospitality
The connection between bio based building systems and tourism is not obvious — until you have tried to build an eco lodge, a glamping structure, or a Tiny House in a frontier market.
Conventional building materials — concrete, steel, industrial insulation — are expensive, carbon heavy, and logistically complex in remote locations. A certified, lightweight, modular bio based building system changes the economics of hospitality infrastructure fundamentally.
CO₂ negative material. Local production potential. Low transport weight. Fast assembly without heavy machinery. These are not marketing claims — they are the operational requirements of every hospitality project I have built or co financed in PNG, Ghana, Kenya, and Uganda.
The market for bio based building systems is growing at approximately 15% CAGR globally. The EU Taxonomy and carbon pricing mechanisms in Denmark, France, and the UK are creating structural demand pull. The window for early stage investment is open — but narrow.
What a Bio Based Building Investor Looks at First
Most bio based building projects do not fail because of a bad idea. They fail because of five operational realities that founders consistently underestimate.
Certification takes 2 to 4 years. From first bench scale test to market ready certification (EN 13501-1, ETA, national building authority approval), the realistic timeline is measured in years, not months. Founders who plan for 6 months are planning to fail.
Moisture behaviour is the most common technical killer. Organic materials absorb water. Without a documented, testable solution for moisture management — vapour barrier, diffusion open membrane, protective cladding — no accredited testing institute will certify the system, and no B2B customer will buy it.
Fire classification requires a physical prototype. U values can be calculated. Fire behaviour cannot. A real prototype must survive a standardised fire test. There are no shortcuts.
Industrialisability defines the business model. A hand built press producing 10 blocks per day is a demonstration tool, not a business. The path from prototype to licensable or industrially scalable production must be planned from the beginning.
Capital requirements are consistently underestimated by a factor of 5 to 10. Between first prototype and first B2B customer, the realistic cost range for certification, testing, and regulatory compliance is €50,000 to €200,000 — not €5,000.
Why Most Projects Fail Before They Begin
This section is the most important part of this article. If you recognise yourself in more than two of these patterns, I am not your investor — not yet.
The prototype is replaced by simulation. Documents, AI research, engineering calculations, and architectural renderings are not prototypes. A prototype is an object you can hold, cut, press, wet, and put in front of a testing laboratory. Until that object exists, nothing has been validated.
Certification is treated as the last step. In reality, certification must be designed into the product from day one. The testing standards — EN norms, OIB guidelines, national building codes — define what the product must be, not what it must prove afterwards.
Universities are misunderstood as co founders. An accredited research institution is a service provider for testing, measurement, and scientific validation. It is not a development partner, not a co founder, and not a free R&D department. If a university contributes technical improvements that are incorporated into the product, they become co inventors under applicable patent law. This must be contractually clarified before any technical conversation begins.
The patent is treated as a shield against everything. A patent protects a precisely defined claim — not an idea. Competitors who use a different material, a different connection mechanism, or a different pressing principle operate entirely legally outside the patent scope. A patent without certification, without a technical partner, and without market traction has limited commercial value.
External validation is blocked out of fear of idea theft. The founders who refuse to show their system to engineers, testing institutes, or universities — without a signed NDA and without any technical details disclosed — are the founders who stay in their garage for years. Legitimate protection is achieved through a filed patent application, a well drafted NDA, and strategic disclosure management. Not through secrecy.
Capital for living is confused with capital for the product. I finance validation — not operations, not living costs, not ongoing business expenses. Every euro I invest must go directly into building, testing, certifying, or structuring the system.
What I Bring to the Table
I describe functional capabilities — not a list of names.
Access to certified testing infrastructure in Austria and the EU. I have direct working relationships with accredited testing and certification pathways — including university research units with dedicated testing equipment for bio based materials, fire testing partners, and national building authority contacts.
Understanding of the EU funding landscape. FFG Innovationscheck (up to €12,000 for initial testing), aws Preseed, FFG Ressourcenwende, CBE JU — I know which instruments apply at which stage of technical readiness, and how to sequence applications for maximum non dilutive financing.
Patent counsel with specific expertise. Personal relationship with one of Austria’s leading patent attorneys specialising in mechanical systems and materials — available from the earliest stage of the process.
Network to industrial strategic buyers. My hospitality investment network includes contacts to major European building material manufacturers and modular construction companies who actively acquire or license innovative building system technologies. The Luxhome/Gropyus precedent — a modular wood building system acquired for over €100 million — is not an exception. It is a market signal.
Capital for Phase 1. Up to €50,000 for the early validation phase — prototype completion, first accredited tests, patent filing, company formation, initial regulatory mapping.
Bio Based Building Investor Criteria: What I Require
I engage with projects that meet the following conditions. These are requirements, not preferences.
A physical prototype exists, or will exist within 60 days. Not a rendering. Not a CAD model. A pressable, cuttable, testable object.
External technical validation is planned and accepted. The founder has identified an accredited testing partner and is prepared to receive — and act on — technical feedback, including critical feedback.
The cladding and all structural materials are nature based. A fully plastic encapsulated system is not relevant to the EU construction market under current and forthcoming regulatory frameworks.
The certification pathway is mapped. The founder understands which norms apply, which testing institutes are involved, and what the realistic timeline looks like.
The business model is license or exit oriented. Building an automated factory requires €50 to €400 million in capital. A startup without that capital does not build a factory — it builds a licensable technology. Founders who insist on owning the full production chain from day one are solving the wrong problem.
Collaboration is structured before capital moves. Investment is preceded by a clear written agreement on roles, equity, IP ownership, and milestone logic. This is not a legal formality — it is the foundation of a functional working relationship.
How a Bio Based Building Investor Assesses the Founder
The project matters. The founder matters more.
These systems operate under intense regulatory pressure, long certification timelines, and high technical uncertainty. The founders who succeed are not the ones with the best idea — they are the ones who can function effectively under those conditions.
How does the founder respond to technical criticism? If an engineer says the moisture management is insufficient, does the founder argue, or does the founder ask what would solve the problem?
Is the founder willing to iterate? The first prototype is never the product. The founder who treats the first version as final is not ready to build a business.
Is the timeline realistic? A founder who expects market ready certification in 12 months has not read the norms. A founder who plans for 36 months and sequences the milestones correctly has done the work.
Has the founder built anything in the last 90 days? Not planned. Not documented. Built. A physical object, a material test, a process. Execution is evidence. Everything else is intention.
Does the founder understand the difference between an idea and a product? An idea is a description of what something could do. A product is an object that does it — repeatedly, under controlled conditions, within defined tolerances.
Who Should Not Contact Me
Briefly and without judgment:
- Projects that exist only in documents
- Founders who do not have — and are not actively building — a physical prototype
- Systems where the primary ask is capital for operating expenses
- Founders who view external technical expertise as a threat rather than a resource
Ready to Connect?
I do not start with a pitch deck review.
Step 1 — Screening request. Send me three sentences: what your system does, what physical validation stage you are at, and whether you have a technical partner. That is all I need to decide whether a first conversation makes sense.
Step 2 — Structured first conversation. If the screening signals genuine readiness, I will schedule a 45 minute call. I will ask specific questions about the technical system, the certification strategy, and the founder’s approach to working under uncertainty.
Many founders reach me directly via WhatsApp — that works too. Keep it short: one paragraph, what you are building, where you are in the process.
- Email: cp@upstyle-consulting.com
- WhatsApp: Quick initial contact
Dr. Conrad Pramböck is CEO of Upstyle Consulting GmbH (Vienna) and managing partner of Upstyle Travel, a hospitality focused investment platform with a portfolio spanning Europe, Africa, and the Pacific. He invests at the intersection of sustainable infrastructure and hospitality.